References
Li D, Wang JM, Li GL, Hao SY, Yang Y, Wu Z, Zhang LW, Zhang JT (2014) Clinical, radiological, and pathological features of 16 papillary glioneuronal tumors. Acta Neurochir 156(4):627–639
Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, ALA-Glioma Study Group (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401
Stummer W, Rodrigues F, Schucht P, Preuss M, Wiewrodt D, Nestler U, Stein M, Artero JM, Platania N, Skjøth-Rasmussen J, Della Puppa A, Caird J, Cortnum S, Eljamel S, Ewald C, González-García L, Martin AJ, Melada A, Peraud A, Brentrup A, Santarius T, Steiner HH, European ALA Pediatric Brain Tumor Study Group (2014) Predicting the “usefulness” of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey. Acta Neurochir 156(12):2315–2324
Valdés PA, Jacobs V, Harris BT, Wilson BC, Leblond F, Paulsen KD, Roberts DW (2015) Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery. J Neurosurg 123(3):771–780
Xiao H, Ma L, Lou X, Gui Q (2011) Papillary glioneuronal tumor: radiological evidence of a newly established tumor entity. J Neuroimaging 21(3):297–302
Zhao RJ, Zhang XL, Chu SG, Zhang M, Kong LF, Wang Y (2016) Clinicopathologic and neuroradiologic studies of papillary glioneuronal tumors. Acta Neurochir 158(4):695–702
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest concerning the materials or methods used in this study or the findings specified in this paper. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Funding
No funding was received for this study.
Ethical approval
We state that no ethics committee approval was required for our study, since it concerns an intraoperative technique that is routinely used in our institution.
Informed consent
Furthermore, informed consent was obtained from the patient, according to the hospital’s ethics guidelines.
Rights and permissions
About this article
Cite this article
Rustemi, O., Gardiman, M.P., Scienza, R. et al. 5-ALA fluorescence applied to glioneuronal tumors. Acta Neurochir 158, 2123–2125 (2016). https://doi.org/10.1007/s00701-016-2971-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-016-2971-5